English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduA new review in Blood Cancer Discovery outlines a key regulatory decision by an FDA committee that greenlights a new biomarker endpoint for accelerated drug approval in multiple myeloma and could cut a decade off the drug development process.
Tag: Drug Approval Process
U.S. lags behind European countries in time from drug approval to reimbursement
A brief research report published in Annals of Internal Medicine found that the U.S. lags behind European countries in time from drug approval to reimbursement.